Factors associated with altmetric attention scores for randomized phase III cancer clinical trials.

被引：0
|
作者：
Rooney, Michael Kevin
Ludmir, Ethan B.
Fuller, Clifton Dave
Warner, Jeremy Lyle
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11014
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials
    Rooney, Michael K.
    Sharifi, Bahareh
    Ludmir, Ethan B.
    Fuller, Clifton D.
    Warner, Jeremy L.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7 : e2300082
  • [2] Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials
    Rooney, Michael K.
    Sharifi, Bahareh
    Ludmir, Ethan B.
    Fuller, Clifton D.
    Warner, Jeremy L.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
  • [3] Performance status restriction in phase III cancer clinical trials.
    Kouzy, Ramez
    Jaoude, Joseph Abi
    Mainwaring, Walker
    Lin, Timothy
    Miller, Austin B.
    Jethanandani, Amit
    Espinoza, Andres F.
    Taniguchi, Cullen M.
    Ludmir, Ethan B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Orthopaedic Randomized Controlled Trials Published in General Medical Journals Are Associated With Higher Altmetric Attention Scores and Social Media Attention Than Nonorthopaedic Randomized Controlled Trials
    Polce, Evan M. Y. Y.
    Kunze, Kyle N.
    Farivar, Daniel
    Fu, Michael C.
    Nwachukwu, Benedict U.
    Nho, Shane J.
    Chahla, Jorge
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2021, 37 (04): : 1261 - 1270
  • [5] Violations of the proportional hazards assumption in randomized phase III oncology clinical trials.
    Rahman, Rifaquat
    Fell, Geoffrey
    Trippa, Lorenzo
    Alexander, Brian Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Analysis of proportion of geriatric patients in phase III cancer clinical trials.
    Gopishetty, Swathi
    Kota, Vamsi
    Guddati, Achuta Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Role of immunotherapy in gastroesophageal cancer with liver metastasis: A meta-analysis of phase III randomized clinical trials.
    Bawek, Sawyer
    Gurusinghe, Sayuri
    Aijaz, Ali
    Attwood, Kristopher
    Mukherjee, Sarbajit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 319 - 319
  • [8] Factors associated with patient attrition in clinical trials.
    Siddiqi, A.
    Holmes-Rovner, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S230 - S230
  • [9] Analysis of racial distribution amongst patients in phase III cancer clinical trials.
    Gopishetty, Swathi
    Gupta, Shruti
    Kota, Vamsi
    Guddati, Achuta Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Trends in the design and interpretation of metastatic colorectal cancer phase III clinical trials.
    Parimi, Sunil
    Raissouni, Soundouss
    Lin, Yongtao
    Monzon, Jose Gerard
    Tang, Patricia A.
    Tam, Vincent Channing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345